Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gensight Biologics

Clinical trials sponsored by Gensight Biologics, explained in plain language.

GenSight Biologics SIGHT EURONEXT PARIS

A gene therapy company focused on retinal diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2 Completed 6

Gene therapy aims to restore sight in rare inherited blindness

Disease control Recruiting now

This study tests a gene therapy called GS010 for people with Leber hereditary optic neuropathy (LHON), a genetic condition that causes rapid vision loss. Researchers will give the treatment as an injection into the eye at two different doses to see if it improves vision and mitoc…

Phase: PHASE2 • Sponsor: GenSight Biologics • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC